Bringing Histology to the Bedside  by Halpern, Allan C. et al.
See related article on page 493
Bringing Histology to the Bedside
Allan C. Halpern, Milind Rajadhyaksha, and Ricardo Toledo-Crow
Dermatology Service, Department of Medicine Memorial Sloan-Kettering Cancer Center, New York, New York, USA
In recent decades, enormous strides have been made in
non-invasive imaging of deep tissues and viscera with the
development and refinement of ultrasonography, compu-
terized axial tomography, magnetic resonance imaging, and
positron emission tomography, to name a few. Progress in
non-invasive skin imaging, however, has been slower than
in other specialties due in part to the ease with which skin is
visually examined and biopsied. The pace of progress in
skin imaging, however, has picked up significantly during
the past decade. Digital skin imaging, standardized whole-
body photography, and dermoscopy are now being used
routinely in many centers to help guide the decision to bi-
opsy pigmented skin lesions (Marghoob et al, 2003). More
recently, high-resolution optical imaging technologies pre-
viously confined to the bench top are finding their way to the
bedside (Gonzalez et al, 2003). In this issue of the Journal of
Investigative Dermatology, an article from the Medical Uni-
versity of Graz, Austria speaks to the potential utility of re-
flectance confocal scanning laser microscopy (reflectance-
CSLM) for the non-invasive bedside evaluation of pigment-
ed lesions. This study and others like it augur a sea change
in the way we will view skin processes clinically at the bed-
side and in small animal translational research studies in the
not too distant future.
Among the available non-invasive techniques for skin
imaging in vivo, confocal microscopy has been the first to
deliver single-cell resolution. A currently available commer-
cial reflectance-CSLM utilizes a diode laser, at the near-
infrared wavelength of 830 nm and a  30, 0.9 numerical
aperture water immersion objective lens, to illuminate skin
with a low power of 2–10 mW, and visualize a microscopic
‘‘optical section’’ within the superficial layers of the skin
(http://www.lucid-tech.com). Nuclear and cellular detail
within the epidermis, and microcirculation and collagen
with the dermis are imaged in en face sections (oriented
parallel to the skin surface) with a measured lateral reso-
lution of 0.7 mm and an axial resolution (i.e., optical section
thickness) of 3 mm, to a maximum depth of 100–200 mm
(depth of the papillary dermis and superficial reticular de-
rmis) (Rajadhyaksha et al, 1995, 1999). Note that the con-
focal resolution is similar to that of histology; in particular,
the confocal section thickness is comparable to the typi-
cally 5 mm thin sections that are prepared for routine his-
tology. Back-scattering of the incident laser light due to
variations in the refractive indices of organelles and ultra-
structures within the tissue provides contrast in the confocal
image (Rajadhyaksha et al, 2004). At a wavelength of 830
nm, melanosomes—due to their size being on the same
order as the illumination wavelength, and melanins—due to
their high refractive index relative to that of the surrounding
skin, produce strong back-scatter. Therefore, melanocytes
and basal keratinocytes rich in melanosomes and melanin
appear bright and with high contrast in reflectance confocal
images (Rajadhyaksha et al, 1995, 1999, 2004).
In this issue of the Journal of Investigative Dermatology,
Gerger et al (2004) describe excellent sensitivity and
specificity achieved for the diagnosis of melanoma using
reflectance-CSLM, based on morphologic features that
were defined a priori from earlier studies (Langley et al,
2001). In a series of 117 melanocytic skin tumors, consisting
of 90 benign and 27 malignant (five in situ, 22 invasive)
melanomas, four of the five observers had diagnostic sen-
sitivities and specificities ranging from 93% to 100%. Sta-
tistical analysis showed excellent to perfect intra-observer
and inter-observer agreement among all five observers for
the ten confocal morphologic attributes studied. Of note,
none of the five observers (which included two dermatology
residents, one dermatologist, and two dermatopathologists)
had prior experience in the interpretation of reflectance
confocal images. They received a 30 min presentation that
instructed them in the confocal morphologic features of
benign nevi versus melanomas, using six images of each.
None of the images in the instruction set were used in the
analysis, and the diagnoses were subsequently made strict-
ly on the basis of the images without knowledge of the
clinical setting, clinical appearance, or dermoscopic ap-
pearance of the lesions. The authors point out the limita-
tions of their study, which include the pre-selection of the
confocal images by a single observer who was not blinded
to the clinical/dermoscopic appearance of the lesions and
the limited generalizability of the results, given the number
of lesions and observers in the data set. A further critique of
the study stems from the lack of histology for a subset of
the benign melanocytic tumors. Nonetheless, the results
provide a ringing endorsement for further assessment of the
utility of reflectance-CSLM for the bedside quasi-histologic
evaluation of pigmented lesions (Pellacani et al, 2004).
Right now, reflectance-CSLM is too expensive and la-
borious to be considered as a screening tool for melanoma,
even if the excellent sensitivity and specificity data pre-
sented by Gerger et al (2004) stand up to further scrutiny.
With minor advances, however, this technology may
become practical for assessing pigmented lesions that
have been selected as suspicious on the basis of clinical
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examination and/or dermoscopy. Although it is unlikely that
reflectance-CSLM will differentiate between severely
dysplastic nevi and melanoma, it may be very useful in dis-
tinguishing lesions requiring excision from those that do not.
Confocal microscopy may significantly improve upon the
diagnostic accuracy currently achieved with dermoscopy,
thus avoiding many currently unnecessary biopsies where-
as maintaining excellent sensitivity for melanoma. It is im-
portant to point out that whereas a skin biopsy is an ‘‘easy’’
procedure to perform, the associated cost, morbidity, and
scarring, especially for facial lesions, are not trivial from the
patient’s perspective.
Improved non-invasive skin imaging has broad implica-
tions beyond the clinical decision to observe or excise
suspicious pigmented lesions. In the clinical arena, reflect-
ance-CSLM has the potential to guide invasive sampling of
complex cutaneous neoplasms, improve pre-surgical and
intra-operative margin detection for cutaneous neoplasms,
and monitor tumor response to non-invasive therapies. In
the research arena, non-invasive quasi-histologic imaging
coupled with molecular/functional imaging has the poten-
tial to revolutionize small animal translational research in
dermatology.
Initial investigations of the utility of reflectance-CSLM are
underway in each of the clinical scenarios outlined above
(Busam et al, 2001; Tannous et al, 2003; Curiel-Lewand-
rowski et al, 2004). Large suspicious cutaneous lesions that
are not amenable to excisional biopsies (e.g., suspected
lentigo maligna of the face) present the challenge of sam-
pling error when partial biopsies are performed. Since con-
focal microscopy scans the skin in the en face plane, it
allows for the ability to scan the entire area of the lesion in
question. Focal areas showing cellular or architectural aty-
pia may thus be slated for directed biopsies. Although
sampling errors most commonly occur in large complex
pigmented lesions, they also occur in melanomas arising in
precursor nevi. Most biopsy specimens undergo very lim-
ited sectioning prior to histologic evaluation, thus permitting
small foci of melanoma to be undetected. Here too, reflect-
ance-CSLM may be utilized, either in vivo or ex vivo, prior to
sectioning to scan the entire lesion and then guide pathol-
ogy sectioning. Another potential use is presurgical and in-
traoperative margin detection for skin cancer surgery.
Surgical management of amelanotic melanomas as well
as melanomas, basal cell carcinomas, and squamous cell
carcinomas with ill-defined borders present a significant
clinical challenge currently addressed by serial excisions or
Mohs’ microscopically controlled surgery. In these settings,
reflectance-CSLM may provide a much improved first ap-
proximation of the lateral borders between the tumor and
normal skin (Busam et al, 2001; Tannous et al, 2003). Con-
focal imaging may also potentially be used for intra-oper-
ative assessment of the deep margins of resection during
Mohs microscopically controlled surgery. In addition to its
potential as an aid to diagnosis and surgical management of
skin cancer, reflectance-CSLM may play a role in clinical
assessment for persistence and recurrence of malignant
lesions undergoing topical therapy (Curiel-Lewandrowski
et al, 2004). With the introduction of topical agents such as
Imiquimod, cutaneous malignancies are increasingly being
treated non-invasively. It is not uncommon, however, for
physicians to misinterpret post-topical therapy-induced
erythema as evidence of cancer persistence. Improvements
in reflectance-CSLM may allow the performance of ‘‘virtual
biopsies’’ to monitor the persistence of tumor on completion
of topical therapy.
The development of the confocal microscope for in vivo
examination of the epidermis, papillary, and superficial re-
ticular dermis at a resolution approaching histological detail
has significant implications for translational research as well
as for clinical care. Real-time confocal microscopy may be
utilized to visualize skin in either reflectance mode or flu-
orescence mode. Whereas the reflectance mode is based
on inherent differences in refractive indices of ultrastruc-
tures within the tissue, the fluorescence mode uses an
exogenous fluorescent agent to generate contrast. We re-
cently developed a dual-contrast confocal microscope that
simultaneously produces fluorescence and reflectance im-
ages, thus providing complementary information and more
detailed ‘‘quasi-histologic’’ morphology of mouse skin
in vivo. The use of combined real-time reflectance and flu-
orescence imaging provides the opportunity for investigat-
ing dynamic changes in the skin. The excellent resolution,
non-invasive, real-time nature of the images acquired, and
growing inventory of fluorescent molecular reporters avail-
able holds significant promise for in vivo studies of tumor
growth, metastasis, and immune response in animal models
of neoplasia. The technique may also be useful for studies
of therapeutic agents, for which reporter fluorophores may
be used to probe the trafficking of specific cell types and/or
the therapeutic agents themselves.
In summary, the future potential of in vivo imaging mo-
dalities such as confocal microscopy to aid clinical der-
matology and translational research looks bright. But in-
strumentation advances and clinical research must occur
before these technologies can be applied in routine clinical
practice. The work presented by Gerger et al in this issue of
the Journal of Investigative Dermatology represents a sig-
nificant contribution to the body of research necessary for
the evaluation and implementation of reflectance-CSLM in
clinical practice. In this regard, it is important to note that
the confocal microscope used by Gerger et al was a first-
generation instrument. These first generation confocal mi-
croscopes are rather time consuming to use and, due to
their complex and bulky configuration, cannot be conven-
iently placed on certain anatomical areas such as the
ear, medial canthus, or on intertriginous areas. As with
other imaging technologies, however, it can be anticipated
that future generation instruments will be electro-opto-
mechanically simpler and more robust, and deliver images
with better resolution and more consistent quality in in-
creasingly compact and cost-effective packages. Advances
in non-invasive ‘‘quasi-histologic’’ skin imaging will not,
however, be limited to improvements in point-scanning re-
flectance confocal microscopy. Recent advances in other
forms of confocal microscopy such as reflectance theta
line-scanning, 1- and 2-photon fluorescence and autofluo-
rescence, and multimodal, as well as broadband optical
coherence tomography all hold promise for improved non-
invasive ‘‘quasi-histologic’’ imaging of the skin. It may be
anticipated that some of these imaging devices, either in-
dependently or in synergistic multimodal combinations, will
BRINGING HISTOLOGY TO THE BEDSIDE ix124 : 3 MARCH 2005




Busam K, Hester K, Charles C, Sachs D, Antonescu C, Gonzalez S, Halpern A:
Detection of clinically amelanotic malignant melanoma and assessment
of its margins by in vivo confocal scanning laser microscopy. Arch De-
rmatol 137:923–929, 2001
Curiel-Lewandrowski C, Williams CM, Swindells KJ, Tahan SR, Astner SA, Fran-
kenthaler R, Gonza´lez S: Use of in vivo confocal microscopy in malignant
melanoma: An aid in diagnosis, and assessment of surgical and non-
surgical therapeutic approaches. Arch Dermatol 140:1127–1132, 2004
Gerger A, Koller S, Kern T, et al: Diagnostic applicability of in vivo confocal laser
scanning microscopy in melanocytic skin tumors. J Invest Dermatol 124 :
493–498, 2004
Gonzalez S, Swindells K, Rajadhyaksha M, Torres A: Changing paradigms in
dermatology: Confocal microscopy in clinical and surgical dermatology.
Clin Dermatol 21:359–369, 2003
Marghoob AA, Swindle LD, Moricz CZM, Sanchez Negron FA, Slue B, Halpern
AC, Kopf AW: Instruments and new technologies for the in vivo diagnosis
of melanoma. J Am Acad Dermatol 49:777–797, 2003
Langley R, Rajadhyaksha M, Dwyer P, Sober A, Flotte T, Anderson RR: Confocal
scanning laser microscopy of benign and malignant melanocytic skin le-
sions in vivo. J Am Acad Dermatol 45:365–376, 2001
Pellacani G, Cesinaro AM, Grana C, Seidenari S: In vivo confocal scanning laser
microscopy of pigmented Spitz nevi: Comparison of in vivo confocal im-
ages with dermoscopy and routine histopathology. J Am Acad Dermatol
51:371–376, 2004
Rajadhyaksha M, Gonzalez S, Zavislan JM: Detectability of contrast agents for
confocal reflectance imaging of skin and microcirculation. J Biomed Opt
9:323–331, 2004
Rajadhyaksha M, Gonzalez S, Zavislan JM, Anderson RR, Webb RH: In vivo
confocal scanning laser microscopy of human skin II: Advances
in instrumentation and comparison to histology. J Invest Dermatol 113:
101–112, 1999
Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR: In vivo
confocal scanning laser microscopy of human skin: Melanin provides
strong contrast. J Invest Dermatol 104:946–952, 1995
Tannous Z, Torres A, Gonzalez S: In vivo real-time confocal reflectance micros-
copy: A noninvasive guide for Mohs micrographic surgery facilitated by
aluminum chloride, an excellent contrast enhancer. Dermatol Surg 29:
839–846, 2003
x HALPERN ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
